Global Endothelin Receptor Antagonist Production, Demand and Key Producers, 2022-2028

October 2022 | 99 pages | ID: G81109BF89A6EN
GlobalInfoResearch

Abstracts

This report studies the global Endothelin Receptor Antagonist demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Endothelin Receptor Antagonist, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Endothelin Receptor Antagonist that contribute to its increasing demand across many markets.

The global Endothelin Receptor Antagonist market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global Endothelin Receptor Antagonist total market, 2017-2028, (USD Million)

Global Endothelin Receptor Antagonist total market by region & country, CAGR, 2017-2028, (USD Million)

U.S. VS China: Endothelin Receptor Antagonist total market, key domestic companies and share, (USD Million)

Global Endothelin Receptor Antagonist revenue by player and market share 2017-2022, (USD Million)

Global Endothelin Receptor Antagonist total market by Type, CAGR, 2017-2028, (USD Million)

Global Endothelin Receptor Antagonist total market by Application, CAGR, 2017-2028, (USD Million)

This reports profiles major players in the global Endothelin Receptor Antagonist market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gilead Sciences Inc., Glaxosmithkline Inc., Sun Pharmaceutical Industries, Inc., Mylan Pharmaceuticals Inc. and Actavis Pharma, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Endothelin Receptor Antagonist market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Endothelin Receptor Antagonist Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Endothelin Receptor Antagonist Market, Segmentation by Type

• Ambrisentan
• Bosentan
• Macitentan

Global Endothelin Receptor Antagonist Market, Segmentation by Application

• Hospital Pharmacy
• Retail Pharmacy
• Mail Order Pharmacy

Companies Profiled:

• Gilead Sciences Inc.
• Glaxosmithkline Inc.
• Sun Pharmaceutical Industries, Inc.
• Mylan Pharmaceuticals Inc.
• Actavis Pharma, Inc.

Key Questions Answered

1. How big is the global Endothelin Receptor Antagonist market?

2. What is the demand of the global Endothelin Receptor Antagonist market?

3. What is the year over year growth of the global Endothelin Receptor Antagonist market?

4. What is the total value of the global Endothelin Receptor Antagonist market?

5. Who are the major players in the global Endothelin Receptor Antagonist market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Endothelin Receptor Antagonist Introduction
1.2 World Endothelin Receptor Antagonist Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Endothelin Receptor Antagonist Total Market by Region
  1.3.1 World Endothelin Receptor Antagonist Market Size by Region (2017-2028)
  1.3.2 United States Endothelin Receptor Antagonist Market Size (2017-2028)
  1.3.3 China Endothelin Receptor Antagonist Market Size (2017-2028)
  1.3.4 Europe Endothelin Receptor Antagonist Market Size (2017-2028)
  1.3.5 Japan Endothelin Receptor Antagonist Market Size (2017-2028)
  1.3.6 South Korea Endothelin Receptor Antagonist Market Size (2017-2028)
  1.3.7 ASEAN Endothelin Receptor Antagonist Market Size (2017-2028)
  1.3.8 India Endothelin Receptor Antagonist Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Endothelin Receptor Antagonist Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Endothelin Receptor Antagonist Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 WORLD ENDOTHELIN RECEPTOR ANTAGONIST COMPANIES COMPETITIVE ANALYSIS

2.1 World Endothelin Receptor Antagonist Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
  2.2.1 Global Endothelin Receptor Antagonist Industry Rank of Major Players
  2.2.2 Global Concentration Ratios (CR4) for Endothelin Receptor Antagonist in 2021
  2.2.3 Global Concentration Ratios (CR8) for Endothelin Receptor Antagonist in 2021
2.3 Endothelin Receptor Antagonist Company Evaluation Quadrant
2.4 Endothelin Receptor Antagonist Market: Overall Company Footprint Analysis
  2.4.1 Endothelin Receptor Antagonist Market: Region Footprint
  2.4.2 Endothelin Receptor Antagonist Market: Company Product Type Footprint
  2.4.3 Endothelin Receptor Antagonist Market: Company Product Application Footprint
2.5 Competitive Environment
  2.5.1 Historical Structure of the Industry
  2.5.2 Barriers of Market Entry
  2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity

3 UNITED STATES VS CHINA VS REST OF THE WORLD

3.1 United States VS China: Endothelin Receptor Antagonist Market Comparison
  3.1.1 United States VS China: Endothelin Receptor Antagonist Market Size Comparison (2017 & 2021 & 2028)
  3.1.2 United States VS China: Endothelin Receptor Antagonist Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Endothelin Receptor Antagonist Major Players and Market Share, 2017-2022
  3.2.1 Major Players of Endothelin Receptor Antagonist in United States, Headquarters (States, Country)
  3.2.2 United States Endothelin Receptor Antagonist Revenue by Domestic Player, (2017-2022)
3.3 China Endothelin Receptor Antagonist Major Players and Market Share, 2017-2022
  3.3.1 Major Players of Endothelin Receptor Antagonist in China, Headquarters (Province, Country)
  3.3.2 China Endothelin Receptor Antagonist Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Endothelin Receptor Antagonist Major Players and Market Share, 2017-2022
  3.4.1 Major Players of Endothelin Receptor Antagonist in Rest of World, Headquarters (State, Country)
  3.4.2 Rest of World Endothelin Receptor Antagonist Revenue by Domestic Player, (2017-2022)

4 MARKET ANALYSIS BY TYPE

4.1 World Endothelin Receptor Antagonist Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
  4.2.1 Ambrisentan
  4.2.2 Bosentan
  4.2.3 Macitentan
4.3 Market Segment by Type
  4.3.1 World Endothelin Receptor Antagonist Market Size by Type (2017-2022)
  4.3.2 World Endothelin Receptor Antagonist Market Size by Type (2023-2028)
  4.3.3 World Endothelin Receptor Antagonist Market Size Market Share by Type (2017-2028)

5 MARKET ANALYSIS BY APPLICATION

5.1 World Endothelin Receptor Antagonist Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
  5.2.1 Hospital Pharmacy
  5.2.2 Retail Pharmacy
  5.2.3 Mail Order Pharmacy
5.3 Market Segment by Application
  5.3.1 World Endothelin Receptor Antagonist Market Size by Application (2017-2022)
  5.3.2 World Endothelin Receptor Antagonist Market Size by Application (2023-2028)
  5.3.3 World Endothelin Receptor Antagonist Market Size by Application (2017-2028)

6 COMPANY PROFILES

6.1 Gilead Sciences Inc.
  6.1.1 Gilead Sciences Inc. Details
  6.1.2 Gilead Sciences Inc. Major Business
  6.1.3 Gilead Sciences Inc. Endothelin Receptor Antagonist Product and Services
  6.1.4 Gilead Sciences Inc. Endothelin Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2022)
  6.1.5 Gilead Sciences Inc. Recent Developments/Updates
  6.1.6 Gilead Sciences Inc. Competitive Strengths & Weaknesses
6.2 Glaxosmithkline Inc.
  6.2.1 Glaxosmithkline Inc. Details
  6.2.2 Glaxosmithkline Inc. Major Business
  6.2.3 Glaxosmithkline Inc. Endothelin Receptor Antagonist Product and Services
  6.2.4 Glaxosmithkline Inc. Endothelin Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2022)
  6.2.5 Glaxosmithkline Inc. Recent Developments/Updates
  6.2.6 Glaxosmithkline Inc. Competitive Strengths & Weaknesses
6.3 Sun Pharmaceutical Industries, Inc.
  6.3.1 Sun Pharmaceutical Industries, Inc. Details
  6.3.2 Sun Pharmaceutical Industries, Inc. Major Business
  6.3.3 Sun Pharmaceutical Industries, Inc. Endothelin Receptor Antagonist Product and Services
  6.3.4 Sun Pharmaceutical Industries, Inc. Endothelin Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2022)
  6.3.5 Sun Pharmaceutical Industries, Inc. Recent Developments/Updates
  6.3.6 Sun Pharmaceutical Industries, Inc. Competitive Strengths & Weaknesses
6.4 Mylan Pharmaceuticals Inc.
  6.4.1 Mylan Pharmaceuticals Inc. Details
  6.4.2 Mylan Pharmaceuticals Inc. Major Business
  6.4.3 Mylan Pharmaceuticals Inc. Endothelin Receptor Antagonist Product and Services
  6.4.4 Mylan Pharmaceuticals Inc. Endothelin Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2022)
  6.4.5 Mylan Pharmaceuticals Inc. Recent Developments/Updates
  6.4.6 Mylan Pharmaceuticals Inc. Competitive Strengths & Weaknesses
6.5 Actavis Pharma, Inc.
  6.5.1 Actavis Pharma, Inc. Details
  6.5.2 Actavis Pharma, Inc. Major Business
  6.5.3 Actavis Pharma, Inc. Endothelin Receptor Antagonist Product and Services
  6.5.4 Actavis Pharma, Inc. Endothelin Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2022)
  6.5.5 Actavis Pharma, Inc. Recent Developments/Updates
  6.5.6 Actavis Pharma, Inc. Competitive Strengths & Weaknesses

7 RAW MATERIAL AND INDUSTRY CHAIN

7.1 Raw Material of Endothelin Receptor Antagonist and Key Manufacturers
7.2 Endothelin Receptor Antagonist Manufacturing Costs
7.3 Endothelin Receptor Antagonist Production Process
7.4 Endothelin Receptor Antagonist Industrial Chain

8 DISTRIBUTION CHANNEL ANALYSIS

8.1 Distribution Channel Breakdown for Endothelin Receptor Antagonist Shipments (%): 2017-2028
  8.1.1 Direct Channel
  8.1.2 Indirect Channel
8.2 Endothelin Receptor Antagonist Typical Distributors
8.3 Endothelin Receptor Antagonist Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Endothelin Receptor Antagonist Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Endothelin Receptor Antagonist Market Size by Region (2017-2022) & (USD Million)
Table 3. World Endothelin Receptor Antagonist Market Size by Region (2023-2028) & (USD Million)
Table 4. World Endothelin Receptor Antagonist Market Size Market Share by Region (2017-2022)
Table 5. World Endothelin Receptor Antagonist Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Endothelin Receptor Antagonist Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Endothelin Receptor Antagonist Players in 2021
Table 9. World Endothelin Receptor Antagonist Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Endothelin Receptor Antagonist Company Evaluation Quadrant
Table 11. Head Office of Key Endothelin Receptor Antagonist Player
Table 12. Endothelin Receptor Antagonist Market: Company Product Type Footprint
Table 13. Endothelin Receptor Antagonist Market: Company Product Application Footprint
Table 14. Endothelin Receptor Antagonist Mergers & Acquisitions Activity
Table 15. United States VS China Endothelin Receptor Antagonist Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Endothelin Receptor Antagonist in United States, Headquarters (States, Country)
Table 17. United States Endothelin Receptor Antagonist Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Endothelin Receptor Antagonist Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Endothelin Receptor Antagonist in China, Company Headquarters (Province, Country)
Table 20. China Endothelin Receptor Antagonist Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Endothelin Receptor Antagonist Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Endothelin Receptor Antagonist in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Endothelin Receptor Antagonist Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Endothelin Receptor Antagonist Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Endothelin Receptor Antagonist Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Endothelin Receptor Antagonist Revenue by Type (2017-2022) & (USD Million)
Table 27. World Endothelin Receptor Antagonist Revenue by Type (2023-2028) & (USD Million)
Table 28. World Endothelin Receptor Antagonist Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Endothelin Receptor Antagonist Revenue by Application (2017-2022) & (USD Million)
Table 30. World Endothelin Receptor Antagonist Revenue by Application (2023-2028) & (USD Million)
Table 31. Gilead Sciences Inc. Basic Information, Manufacturing Base and Competitors
Table 32. Gilead Sciences Inc. Major Business
Table 33. Gilead Sciences Inc. Endothelin Receptor Antagonist Product and Services
Table 34. Gilead Sciences Inc. Endothelin Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Gilead Sciences Inc. Recent Developments/Updates
Table 36. Gilead Sciences Inc. Competitive Strengths & Weaknesses
Table 37. Glaxosmithkline Inc. Basic Information, Manufacturing Base and Competitors
Table 38. Glaxosmithkline Inc. Major Business
Table 39. Glaxosmithkline Inc. Endothelin Receptor Antagonist Product and Services
Table 40. Glaxosmithkline Inc. Endothelin Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Glaxosmithkline Inc. Recent Developments/Updates
Table 42. Glaxosmithkline Inc. Competitive Strengths & Weaknesses
Table 43. Sun Pharmaceutical Industries, Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Sun Pharmaceutical Industries, Inc. Major Business
Table 45. Sun Pharmaceutical Industries, Inc. Endothelin Receptor Antagonist Product and Services
Table 46. Sun Pharmaceutical Industries, Inc. Endothelin Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Sun Pharmaceutical Industries, Inc. Recent Developments/Updates
Table 48. Sun Pharmaceutical Industries, Inc. Competitive Strengths & Weaknesses
Table 49. Mylan Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 50. Mylan Pharmaceuticals Inc. Major Business
Table 51. Mylan Pharmaceuticals Inc. Endothelin Receptor Antagonist Product and Services
Table 52. Mylan Pharmaceuticals Inc. Endothelin Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Mylan Pharmaceuticals Inc. Recent Developments/Updates
Table 54. Actavis Pharma, Inc. Basic Information, Manufacturing Base and Competitors
Table 55. Actavis Pharma, Inc. Major Business
Table 56. Actavis Pharma, Inc. Endothelin Receptor Antagonist Product and Services
Table 57. Actavis Pharma, Inc. Endothelin Receptor Antagonist Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 58. Endothelin Receptor Antagonist Raw Material
Table 59. Key Manufacturers of Endothelin Receptor Antagonist Raw Materials
Table 60. Endothelin Receptor Antagonist Typical Distributors
Table 61. Endothelin Receptor Antagonist Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Endothelin Receptor Antagonist Picture
Figure 2. World Endothelin Receptor Antagonist Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Endothelin Receptor Antagonist Total Market Size (2017-2028) & (USD Million)
Figure 4. World Endothelin Receptor Antagonist Market Size Market Share by Region (2017-2028)
Figure 5. United States Endothelin Receptor Antagonist Market Size (2017-2028) & (USD Million)
Figure 6. China Endothelin Receptor Antagonist Market Size (2017-2028) & (USD Million)
Figure 7. Europe Endothelin Receptor Antagonist Market Size (2017-2028) & (USD Million)
Figure 8. Japan Endothelin Receptor Antagonist Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Endothelin Receptor Antagonist Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Endothelin Receptor Antagonist Market Size (2017-2028) & (USD Million)
Figure 11. India Endothelin Receptor Antagonist Market Size (2017-2028) & (USD Million)
Figure 12. Endothelin Receptor Antagonist Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Endothelin Receptor Antagonist by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Endothelin Receptor Antagonist Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Endothelin Receptor Antagonist Markets in 2021
Figure 17. United States VS China: Endothelin Receptor Antagonist Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Endothelin Receptor Antagonist Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Endothelin Receptor Antagonist Market Size Market Share by Type in 2021
Figure 20. Ambrisentan
Figure 21. Bosentan
Figure 22. Macitentan
Figure 23. World Endothelin Receptor Antagonist Market Size Market Share by Type (2017-2028)
Figure 24. World Endothelin Receptor Antagonist Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 25. World Endothelin Receptor Antagonist Market Size Market Share by Application in 2021
Figure 26. Hospital Pharmacy
Figure 27. Retail Pharmacy
Figure 28. Mail Order Pharmacy
Figure 29. World Endothelin Receptor Antagonist Market Size Market Share by Application (2017-2028)
Figure 30. Manufacturing Cost Structure Analysis of Endothelin Receptor Antagonist in 2021
Figure 31. Manufacturing Process Analysis of Endothelin Receptor Antagonist
Figure 32. Endothelin Receptor Antagonist Industrial Chain
Figure 33. Distribution Channel Breakdown for Endothelin Receptor Antagonist Shipments (%): 2017-2028
Figure 34. Direct Channel Pros & Cons
Figure 35. Indirect Channel Pros & Cons
Figure 36. Methodology
Figure 37. Research Process and Data Source